Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions
- PMID: 27570728
- PMCID: PMC4996479
- DOI: 10.1007/s40429-016-0098-7
Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions
Abstract
Adolescence is a key period in the development of substance use and misuse. Substance use typically begins during adolescence and prevalence rates for many substance use disorders peak before age 21 years. Yet, despite clinical demand, treatments for youth rely almost entirely on psychosocial interventions that yield only modest benefit. One potential way to improve treatment effects is to augment the best available psychosocial interventions with pharmacotherapy. Although pharmacotherapy research has advanced care for adults with substance use disorders, no medication is indicated for adolescents and controlled trials with teenagers are scant. Optimizing treatments for youth will require closing this important gap in medication development research. In this paper we review the paucity of pharmacotherapy research for adolescent substance misuse, and we discuss how we can leverage human laboratory paradigms and technology to advance our understanding regarding if and how medications may improve treatment options for youths.
Keywords: Adolescents; Ecological Momentary Assessment; Human Laboratory; Medication; Pharmacotherapy; Review; Substance Use.
References
-
- Services USDoHaH The Surgeon General's Call to Action to Prevent and Reduce Underage Drinking. 2007 Jul; - PubMed
-
- Johnston LD, O'Malley PM, Miech RA, Bachman JG, Schulenberg J. Monitoring the Future Results on Drug Use: 1975-2014. Overview of Key Findings. 2015
-
- Adolescent substance use: America's #1 Public Health Problem. Atlanta, GA: 2011. The National Center on Addiction and Substance Abuse (CASA) at Columbia University.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous